Be a Smart Investor
Friday, December 22, 2017
Roche to buy US cancer drugmaker Ignyta for $1.7 billion
The move will broaden Roche's oncology portfolio globally, the companies said on Friday.
from Mergers and Acquisitions http://ift.tt/2BWQ1GM
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment